Study of HS-20117 Combination Therapy for Advanced Solid Tumors
Part of Cancer, Digestive system, Lungs & breathing clinical trials.
This early-phase trial tests a new drug (HS-20117) combined with other drugs for people with advanced solid tumors. It aims to see if the combination is safe and effective, especially for cancers that have not responded to other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You have advanced cancer (solid tumor) that has spread or cannot be removed by surgery, and at least one tumor that can be measured on a scan.
- You should be able to do your daily activities mostly on your own (ECOG 0-1) and have a life expectancy of at least 12 weeks.
- You cannot have had certain prior treatments, including drugs targeting MET or EGFR, or certain other cancer treatments within the last 2–4 weeks.
- You must not have active or untreated brain metastases, serious heart problems, or a serious infection in the last 4 weeks.
- You must be willing to use effective birth control during the study and not be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests HS-20117 to see if it is safe and how well it works in people with advanced solid tumors. You may qualify if your cancer has progressed after standard treatments (or you can’t tolerate them) and you can provide new or stored tumor tissue for testing.
This trial is testing a new drug called HS-20110 for people with advanced solid tumors that have not responded to other treatments. It aims to see if the drug is safe and can shrink tumors.
This trial tests a new drug (HS-10370) in combination with other cancer treatments for people with advanced solid tumors that have a specific genetic change (KRAS G12C). It's for patients who have tried standard options without success.
This trial tests a new drug, HRS-7058, combined with other anti-cancer drugs for people with advanced solid tumors that cannot be surgically removed. The goal is to see if the combination can shrink tumors or slow their growth.
This trial tests a new combination treatment (HC010) for people with advanced solid tumors that have spread or cannot be removed by surgery. It aims to see if the drug is safe and effective.
This trial tests a new drug called HS-20122 in people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and effective.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.